Clinical Benefit of Avapritinib in <i>KIT-</i> Mutant Gastrointestinal Stromal Tumors: A <i>Post Hoc</i> Analysis of the Phase I NAVIGATOR and Phase I/II CS3007–001 Studies

Michael C. Heinrich, Lin Shen, Robin L. Jones et al.|Clinical Cancer Research|2023

Cited by 9